MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fphar.2026.1726508

Медицинская библиотека · Frontiers in pharmacology · 2026

NAPQI adducts in patients with selective hypersensitivity to acetaminophen.

Gomez-Tabales Javier, García-Menaya Jesus M, Blanca-Lopez Natalia, Cerezo-Arias María de Las Olas, Silva-Rodríguez Antonio, Ayuso Pedro, García-Martín Elena, Agúndez José A G

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Acetaminophen, a widely used analgesic and antipyretic, can cause adverse reactions ranging from mild urticaria to severe anaphylaxis. While interindividual differences in pharmacokinetics and genetic polymorphisms are known to affect acetaminophen metabolism, the specific mechanisms underlying hypersensitivity reactions (HSRs) remain unclear.

METHODS

We evaluated 28 patients with single-NSAID-induced urticaria/angioedema or anaphylaxis, but no other symptoms after acetaminophen intake. All patients demonstrated selective hypersensitivity to acetaminophen while exhibiting confirmed tolerance to acetylsalicylic acid (ASA). Oral provocation tests were conducted, and NAPQI adducts and acetaminophen metabolites were quantified in serum samples using HPLC coupled with mass spectrometry in these patients and in control individuals.

RESULTS

NAPQI generation occurred early after drug administration, within the timeframe when immediate HSRs occur. NAPQI adducts were 3-fold higher in patients with positive oral provocation compared to patients with negative oral provocation, (P = 0.028), despite lower acetaminophen doses. Detoxified NAPQI metabolites were reduced in HSR individuals, suggesting impaired detoxification. A trend toward higher adduct levels was observed in individuals with GSTM1 null genotypes.

CONCLUSION

Our findings indicate that NAPQI adduct generation is closely related to acetaminophen HSRs, supporting a mechanistic link between impaired NAPQI detoxification and acetaminophen HSR. Genetic variability in detoxifying enzymes, particularly GSTM1, may modulate individual susceptibility. These findings warrant further investigation into NAPQI adducts as predictive biomarkers for acetaminophen hypersensitivity.

Для цитирования: Gomez-Tabales Javier, García-Menaya Jesus M, Blanca-Lopez Natalia, Cerezo-Arias María de Las Olas, Silva-Rodríguez Antonio, Ayuso Pedro, García-Martín Elena, Agúndez José A G. NAPQI adducts in patients with selective hypersensitivity to acetaminophen.. Frontiers in pharmacology. 2026. DOI: 10.3389/fphar.2026.1726508.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.